The rise and fall of troglitazone
- 1 June 2000
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 17 (6) , 414-415
- https://doi.org/10.1046/j.1464-5491.2000.00315.x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Long-term effects of troglitazone: open-label extension studies in type 2 diabetic patients.Diabetes Care, 2000
- Thiazolidinediones: a new class of antidiabetic drugsDiabetic Medicine, 1999
- Troglitazone-Associated Hepatic FailureAnnals of Internal Medicine, 1999
- Fatal Hepatotoxicity Associated with TroglitazoneAnnals of Internal Medicine, 1998
- Troglitazone-Induced Hepatic Failure Leading to Liver Transplantation: A Case ReportAnnals of Internal Medicine, 1998
- Hepatic Dysfunction Associated with TroglitazoneNew England Journal of Medicine, 1998
- Effect of Troglitazone in Insulin-Treated Patients with Type II Diabetes MellitusNew England Journal of Medicine, 1998
- Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes MellitusAnnals of Internal Medicine, 1998
- Thiazolidinediones in the Treatment of Insulin Resistance and Type II DiabetesDiabetes, 1996
- Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patientsDiabetologia, 1996